PGIL Q3 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹1,170 Cr
verified against source
Revenue YoY
14.4%
reported change
EBITDA
₹97 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Pearl Global delivered its highest Q3 revenue in 5 years at ₹1,170 cr (up 14.4% YoY), driven by Vietnam and Indonesia growth, despite tariff headwinds of ₹31 cr impacting margins. The India-US bilateral trade deal reducing tariffs from 50% to 18% is a transformative event, while India-EU and India-UK FTAs provide additional tailwinds. PAT grew 6.8% to ₹52 cr with EBITDA margins of 8.3% (9% excluding tariff and ramp-up costs). Management targets 12-15% revenue CAGR and double-digit EBITDA margins as capacity expansions in Bangladesh (6M pieces by Q2 FY27) and Bihar (900 machines) come online. Guatemala losses should halve by FY27; India operations at ₹1,100 cr run rate can scale to ₹1,600 cr with existing infrastructure. Key risk: US consumer demand softening as brands surgically pass through 20% tariff increases with buyers already reducing piece counts.
Colored figures show movement against the previous available record.
Guidance to track
- Management maintains group-level guidance of 12-15% revenue growth with continuous efforts to beat this number, supported by FDA tailwinds across all major markets.
- Current India run rate of ₹1,100 cr can scale to ₹1,600+ cr with existing in-house capacity; two partnership factories provide additional buffer for FY27+ acceleration.
- Targeting double-digit EBITDA margins at both standalone India and group level, with FDA implementation and operational efficiencies expected to drive improvement from FY27.
- US tariff headwind of ₹31 cr (9-month) to reduce substantially from FY27; ramp-up costs in Bihar and Guatemala to decline in Q4 with significant reduction from next financial year.
Risks flagged
- Brands are surgically passing through tariff costs with some reducing piece counts; early signs show buyers moderating volumes as price tickets inch up, potentially impacting Q4 and beyond.
- Nearshore facility remains constrained by raw material scarcity (tariff advantage only applies when sourcing locally); management expects break-even in FY27 but acknowledges the puzzle of making it profitable.
- India lacks variety of synthetic/fabric raw materials compared to Bangladesh and Vietnam; competitiveness depends on continued investment in fiber diversification and supplier ecosystem.
- When asked to quantify tariff discount absorption split between revenue reduction vs. expense, management deferred to offline discussion, indicating ongoing sensitivity around pricing adjustments.
Key quotes
- A major and long-awaited development was the India US bilateral trade deal which reduces the tariff from 50% to 18%, significantly enhancing India's textile export competitiveness.
- The only risk that I see is many retailers had have a very high exposure to Bangladesh. So for example Bangladesh is today known for denim manufacturing. They have almost like 90% or 100% of their business coming off from one country.
- Certainly our target is to really move to those double-digit EBITDA at standalone and at a group level and we are definitely working towards it. All this FDA and the trade barrier going out and one of the costs also getting cooled down next financial year we are well positioned to achieve this double-digit number.
Research modules